Abstract
Parkinsonian syndrome is the clinical expression of a lesion within the nigro-striatal dopaminergic pathway. Akinesia is the main manifestation of parkinsonism. The clinical analysis of motor symptoms may guide clinical diagnosis. Parkinson's disease is characterized by a pure asymmetric parkinsonian syndrome, responsive to dopaminergic treatment. The evolution of Parkinson's disease is characterized by the occurrence of motor complications (dyskinesia and fluctuations). Gait disturbances (postural instability and freezing) are late in Parkinson's disease. When early (within the first three years), they point to atypical parkinsonian syndrome.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.
MeSH terms
-
Antiparkinson Agents / adverse effects
-
Antiparkinson Agents / therapeutic use
-
Articulation Disorders / etiology
-
Articulation Disorders / physiopathology
-
Corpus Striatum / physiopathology
-
Deglutition Disorders / etiology
-
Deglutition Disorders / physiopathology
-
Disease Progression
-
Dopamine Agonists / adverse effects
-
Dopamine Agonists / therapeutic use
-
Dopaminergic Neurons / pathology
-
Dopaminergic Neurons / physiology
-
Gait Disorders, Neurologic / etiology
-
Gait Disorders, Neurologic / physiopathology
-
Humans
-
Hypokinesia / etiology
-
Hypokinesia / physiopathology
-
Levodopa / adverse effects
-
Levodopa / therapeutic use
-
Movement / physiology
-
Muscle Hypertonia / etiology
-
Muscle Hypertonia / physiopathology
-
Parkinson Disease / complications
-
Parkinson Disease / drug therapy
-
Parkinson Disease / physiopathology
-
Parkinsonian Disorders / complications
-
Parkinsonian Disorders / drug therapy
-
Parkinsonian Disorders / physiopathology*
-
Postural Balance
-
Sensation Disorders / etiology
-
Sensation Disorders / physiopathology
-
Substantia Nigra / physiopathology
-
Tremor / etiology
-
Tremor / physiopathology
Substances
-
Antiparkinson Agents
-
Dopamine Agonists
-
Levodopa